Now Recruiting: New immunity clinical trial for adults 65 years and older
Qu Biologics' Site Specific Immunomodulators (SSIs) are designed to restore normal immune function to treat and prevent cancer and chronic inflammatory diseases.
Helping the Body Heal Itself
The important Role of Natural Immunity in Health and Aging with Dr. Hal Gunn, MD.
Location: White Rock Community Centre
Qu Biologics' Site Specific Immunomodulators (SSIs) are designed to restore normal immune function to treat and prevent cancer and chronic inflammatory diseases.
Helping the Body Heal Itself
The important Role of Natural Immunity in Health and Aging with Dr. Hal Gunn, MD.
Location: Online on Zoom
Qu Biologics' Site Specific Immunomodulators (SSIs) are designed to restore normal immune function to treat and prevent cancer and chronic inflammatory diseases.
Helping the Body Heal Itself
Transformational Science
Qu Biologics is pioneering the development of SSIs, a first-in-class immunotherapy platform. SSIs emerged from Qu’s seminal discovery that the body’s natural immune response may be harnessed and directed to specific organs. SSIs overcome immune dysfunction that underlies cancer, chronic inflammatory diseases, and aging.
Mission Statement
Qu’s mission is to transform the treatment and prevention of cancer and chronic inflammatory diseases by restoring the full breadth of normal immune function.
Current Clinical Trials
Qu Biologics currently has two Phase 2 randomized double-blind placebo-controlled clinical trials in progress:
Our RESILIENCE Study is designed to evaluate whether Qu’s QBKPN SSI immunomodulator can improve immune function in people 65 years of age or older, including how well it can protect against respiratory and other infections and what effect it has on maintaining or improving quality of life, activity level, and health status.
Our PERIOP-06 Study is designed to evaluate whether Qu’s QBECO SSI can prevent post-operative innate immune suppression and improve survival in people with late-stage colon cancer undergoing surgery for liver metastasis.
Pipeline
Qu Biologics is advancing the promise of SSIs across multiple important diseases, including oncology, chronic inflammatory diseases, and diseases of aging.
Latest News
Clinical News, News
Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly
MoreClinical News, News, Partnerships
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer
MoreNews, Partnerships
Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding
MoreLatest Events
join us
Careers
Join a team of innovators who have a passion to make a difference. Our ambitious team
has achieved a number of major milestones, and we have many big goals ahead.